Neuland Laboratories Limited (BOM:524558)
16,516
+348 (2.15%)
At close: Oct 31, 2025
Neuland Laboratories Revenue
Neuland Laboratories had revenue of 2.93B INR in the quarter ending June 30, 2025, a decrease of -33.41%. This brings the company's revenue in the last twelve months to 13.30B, down -18.66% year-over-year. In the fiscal year ending March 31, 2025, Neuland Laboratories had annual revenue of 14.77B, down -5.24%.
Revenue (ttm)
13.30B
Revenue Growth
-18.66%
P/S Ratio
15.93
Revenue / Employee
7.41M
Employees
1,794
Market Cap
211.90B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 14.77B | -817.43M | -5.24% |
| Mar 31, 2024 | 15.59B | 3.67B | 30.81% |
| Mar 31, 2023 | 11.91B | 2.40B | 25.20% |
| Mar 31, 2022 | 9.52B | 147.07M | 1.57% |
| Mar 31, 2021 | 9.37B | 1.73B | 22.64% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 10.00T |
| Life Insurance Corporation of India | 9.04T |
| State Bank of India | 3.50T |
| Larsen & Toubro | 2.76T |
| HDFC Bank | 2.68T |
| Tata Consultancy Services | 2.58T |
| ICICI Bank | 1.91T |
| Bharti Airtel | 1.84T |
Neuland Laboratories News
- 6 weeks ago - Neuland Labs shares surge over 2% as exports jump 433% YoY in August - Business Upturn
- 3 months ago - Neuland Laboratories shares fall nearly 4% after weak Q1 results - Business Upturn
- 3 months ago - Over 40 stocks trade ex-dividend today; Kotak Mahindra Bank, Bharti Airtel, Cummins, Dabur, Intellect Design, Birlasoft, Neuland Labs in focus - Business Upturn
- 6 months ago - Neuland Laboratories share price drops 5% as Q4 EBITDA falls 52.3% YoY to Rs 51 crore - Business Upturn
- 6 months ago - Neuland Laboratories receives one FDA observation following inspection of Unit 2 facility in Telangana - Business Upturn
- 9 months ago - Neuland Laboratories shares drop 6% as Q3 EBITDA falls 29% YoY - Business Upturn
- 9 months ago - Neuland Laboratories Q3 FY25 Results: Net Profit surges 24.9% YoY, Revenue flat at Rs 398.03 crore - Business Upturn
- 10 months ago - Neuland Labs shares surge 3% after Rs 342 crore capex plan approval - Business Upturn